Cargando…
Dual Therapeutic Action of a Neutralizing Anti-FGF2 Aptamer in Bone Disease and Bone Cancer Pain
Fibroblast growth factor 2 (FGF2) plays a crucial role in bone remodeling and disease progression. However, the potential of FGF2 antagonists for treatment of patients with bone diseases has not yet been explored. Therefore, we generated a novel RNA aptamer, APT-F2, specific for human FGF2 and chara...
Autores principales: | Jin, Ling, Nonaka, Yosuke, Miyakawa, Shin, Fujiwara, Masatoshi, Nakamura, Yoshikazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154475/ https://www.ncbi.nlm.nih.gov/pubmed/27506449 http://dx.doi.org/10.1038/mt.2016.158 |
Ejemplares similares
-
Anti-Angiogenic and Anti-Scarring Dual Action of an Anti-Fibroblast Growth Factor 2 Aptamer in Animal Models of Retinal Disease
por: Matsuda, Yusaku, et al.
Publicado: (2019) -
Multiple Therapeutic Applications of RBM-007, an Anti-FGF2 Aptamer
por: Nakamura, Yoshikazu
Publicado: (2021) -
A Chymase Inhibitory RNA Aptamer Improves Cardiac Function and Survival after Myocardial Infarction
por: Jin, Denan, et al.
Publicado: (2018) -
Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application
por: Adachi, Tatsuo, et al.
Publicado: (2019) -
FGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice
por: Sun, Ningyuan, et al.
Publicado: (2015)